Back to Results
First PageMeta Content
Cell lines / Cancer research / Urology / DU145 / Cell culture / Prostate cancer / Paclitaxel / Catenin / CDH1 / Biology / Medicine / Cell biology


Acquisition of paclitaxel resistance is associated with a more aggressive and invasive phenotype in prostate cancer
Add to Reading List

Document Date: 2013-01-08 16:47:44


Open Document

File Size: 1,87 MB

Share Result on Facebook

Company

Wilson / Wiley Periodicals Inc. / /

Country

Germany / Jordan / United States / /

/

Facility

University of ErlangenNuremberg / James Buchanan Brady Urological Institute / Oncology Center / The Johns Hopkins University / University School / /

/

IndustryTerm

treatment of advanced prostate cancer / online version / epithelial cell machinery / well-structured and dynamic network / energy / /

MedicalCondition

advanced disease / produced tumours / advanced prostate cancer / cytoskeletal remodeling Introduction Prostate cancer / common cancer / cancer / disease / chronic treatment / larger and rapidly-growing tumours / tumour / prostate cancer / tumours / /

MedicalTreatment

chemotherapy / /

Organization

6In Vivo Cellular and Molecular Imaging Center / University School of Medicine / Whiting School of Engineering / University of ErlangenNuremberg / The Johns Hopkins University / Bloomberg School of Public Health / James Buchanan Brady Urological Institute / Oncology Center / FDA / James Buchanan Brady Urological Institute Department of Urology / Department of Urology / /

Person

James Buchanan / Marburg Baltimore / Steven M. Mooney / Steven S. An / /

/

Position

reporter / /

Product

paclitaxel / /

ProvinceOrState

Maryland / /

Technology

gene expression / chemotherapy / apoptosis / /

SocialTag